Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 15

Results For "NFI"

1513 News Found

Biocon Foundation, BeST Cluster and NCBS launch first BioWISE Cohort for postgraduate women students
Biotech | April 03, 2026

Biocon Foundation, BeST Cluster and NCBS launch first BioWISE Cohort for postgraduate women students

Empowering 15 Women in STEM (Life Sciences) with scholarship, internship and mentorship


Molbio’s digital radiology arm secures CE MDR certification for its medical imaging portfolio
Medical Device | April 02, 2026

Molbio’s digital radiology arm secures CE MDR certification for its medical imaging portfolio

Certification by TÜV SÜD Product Service GmbH reinforces the company's commitment to globally benchmarked standards in safety, quality, and performance


Lupin completes acquisition of VISUfarma
News | April 02, 2026

Lupin completes acquisition of VISUfarma

The move represents a significant milestone in Lupin’s strategy to expand its specialty care portfolio and strengthen its presence in Europe


Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy
Drug Approval | April 02, 2026

Biogen bags FDA nod for high dose SPINRAZA in spinal muscular atrophy

The new regimen, delivering 50 mg/5 mL and 28 mg/5 mL doses, offers a higher concentration of the drug for both loading and maintenance phases


Rusan unveils APOSAN 3ml multi-dose pen
News | April 01, 2026

Rusan unveils APOSAN 3ml multi-dose pen

The company now offers the complete range of Apomorphine Hydrochloride in different fill volumes


Investigational therapy efzimfotase alfa shows promising Phase III results in rare bone disease
Clinical Trials | April 01, 2026

Investigational therapy efzimfotase alfa shows promising Phase III results in rare bone disease

Efzimfotase alfa is an investigational enzyme replacement therapy designed to reduce injection volume


Allergan Aesthetics showcases breakthroughs at AAD 2026
Clinical Trials | March 31, 2026

Allergan Aesthetics showcases breakthroughs at AAD 2026

Allergan also presented new insights on the growing population of patients on GLP-1 agonists for weight loss who are seeking aesthetic treatments


Corona Remedies acquires antiseptic brand Wokadine from Dr Reddy’s to enter Iodine market
News | March 31, 2026

Corona Remedies acquires antiseptic brand Wokadine from Dr Reddy’s to enter Iodine market

This strategic acquisition enables CORONA Remedies to penetrate deeper into targeted specialty and offer wider accessibility


Sun Pharma to spotlight 14 dermatology studies at 2026 AAD annual meeting
News | March 30, 2026

Sun Pharma to spotlight 14 dermatology studies at 2026 AAD annual meeting

The presentations underscore the company’s deep expertise in dermatology and immunology